{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:35:36Z","timestamp":1791272136260,"version":"4.1.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/mop.0b013e328321882e","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T07:48:36Z","timestamp":1242892116000},"page":"15-21","source":"Crossref","is-referenced-by-count":75,"title":["Current issues in blood transfusion for sickle cell disease"],"prefix":"10.1097","volume":"21","author":[{"given":"Shannon","family":"Wahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith C","family":"Quirolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210206","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N Engl J Med"},{"key":"R2-4-20210206","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1172\/JCI118355","article-title":"In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse","volume":"96","author":"Kaul","year":"1995","journal-title":"J Clin Invest"},{"key":"R3-4-20210206","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2141.2008.07097.x","article-title":"Advances in clinical research in sickle cell disease","volume":"141","author":"Hagar","year":"2008","journal-title":"Br J Haematol"},{"key":"R4-4-20210206","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/0003-4819-48-2-398","article-title":"Surgical management of sickle cell anemia: the use of packed red blood cell transfusions","volume":"48","author":"Madel","year":"1958","journal-title":"Ann Intern Med"},{"key":"R5-4-20210206","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0022-3476(78)80317-5","article-title":"Excretion of iron in response to deferoxamine in sickle cell anemia","volume":"92","author":"Cohen","year":"1978","journal-title":"J Pediatr"},{"key":"R6-4-20210206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000467637","article-title":"IgM lymphocytotoxic antibodies following multiple transfusion","volume":"21","author":"Crome","year":"1971","journal-title":"Vox Sang"},{"key":"R7-4-20210206","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1537-2995.1989.29289146827.x","article-title":"Human immunodeficiency virus seroprevalence among blood product recipients in San Francisco before transfusion","volume":"29","author":"Hwang","year":"1989","journal-title":"Transfusion"},{"key":"R8-4-20210206","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ajcp\/55.6.662","article-title":"Comparative studies of height and weight as a blood volume reference standard in normal children and children with sickle cell anemia","volume":"55","author":"Gross","year":"1971","journal-title":"Am J Clin Pathol"},{"key":"R9-4-20210206","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0037-1963(01)90057-5","article-title":"Techniques for blood administration in sickle cell patients","volume":"38","author":"Eckman","year":"2001","journal-title":"Semin Hematol"},{"key":"R10-4-20210206","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ajh.20385","article-title":"Myocardial injury or infarction associated with fat embolism in sickle cell disease: a report of three cases with survival","volume":"80","author":"Dang","year":"2005","journal-title":"Am J Hematol"},{"key":"R11-4-20210206","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.hoc.2005.08.006","article-title":"Arterial blood pressure and hyperviscosity in sickle cell disease.","volume":"19","author":"Johnson","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"R12-4-20210206","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mpd.2001.119593","article-title":"Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia","volume":"139","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"key":"R13-4-20210206","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1542\/peds.2006-1241","article-title":"Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids","volume":"118","author":"Strouse","year":"2006","journal-title":"Pediatrics"},{"key":"R14-4-20210206","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0037-1963(01)90025-3","article-title":"Principles and problems of transfusion in sickle cell disease","volume":"38","author":"Telen","year":"2001","journal-title":"Semin Hematol"},{"key":"R15-4-20210206","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"R16-4-20210206","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"key":"R17-4-20210206","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group","volume":"333","author":"Vichinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"R18-4-20210206","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2141.2006.06409.x","article-title":"Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2","volume":"136","author":"Styles","year":"2007","journal-title":"Br J Haematol"},{"key":"R19-4-20210206","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-3476(05)82006-2","article-title":"Effects of a long-term transfusion regimen on sickle cell-related illnesses","volume":"125","author":"Styles","year":"1994","journal-title":"J Pediatr"},{"key":"R20-4-20210206","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jca.20129","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis","volume":"22","author":"Szczepiorkowski","year":"2007","journal-title":"J Clin Apher"},{"key":"R21-4-20210206","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1537-2995.2007.01434.x","article-title":"Blood bank management of sickle cell patients at comprehensive sickle cell centers","volume":"47","author":"Afenyi-Annan","year":"2007","journal-title":"Transfusion"},{"key":"R22-4-20210206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0037-1963(01)90056-3","article-title":"Current issues with blood transfusions in sickle cell disease","volume":"38","author":"Vichinsky","year":"2001","journal-title":"Semin Hematol"},{"key":"R23-4-20210206","first-page":"99","article-title":"Transfusion therapy in pediatric sickle cell disease","volume":"5","author":"Quirolo","year":"2006","journal-title":"Blood Ther Med"},{"key":"R24-4-20210206","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1098-1101(1999)14:3<122::AID-JCA3>3.0.CO;2-A","article-title":"Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload","volume":"14","author":"Singer","year":"1999","journal-title":"J Clin Apher"},{"key":"R25-4-20210206","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/pbc.20252","article-title":"Cathlink 20: a subcutaneous implanted central venous access device used in children with sickle cell disease on long-term erythrocytapheresis \u2013 a report of low complication rates","volume":"44","author":"Raj","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R26-4-20210206","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00043426-199511000-00011","article-title":"Long-term central venous access in patients with sickle cell disease. Incidence of thrombotic and infectious complications","volume":"17","author":"Abdul-Rauf","year":"1995","journal-title":"J Pediatr Hematol Oncol"},{"key":"R27-4-20210206","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2257.1996.00154.x","article-title":"Experience with the Port-A-Cath in sickle cell disease","volume":"18","author":"McCready","year":"1996","journal-title":"Clin Lab Haematol"},{"key":"R28-4-20210206","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajh.10047","article-title":"Central venous catheter complications in sickle cell disease","volume":"69","author":"Jeng","year":"2002","journal-title":"Am J Hematol"},{"key":"R29-4-20210206","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.RVI.0000121410.46920.6E","article-title":"Infectious complications of implantable venous access devices in patients with sickle cell disease","volume":"15","author":"Wagner","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"R30-4-20210206","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1522-726X(200002)49:2<160::AID-CCD9>3.0.CO;2-8","article-title":"Aortic laceration secondary to palmaz stent placement for treatment of superior vena cava syndrome","volume":"49","author":"Evans","year":"2000","journal-title":"Catheter Cardiovasc Interv"},{"key":"R31-4-20210206","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion"},{"key":"R32-4-20210206","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"R33-4-20210206","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1537-2995.2001.41091086.x","article-title":"Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial","volume":"41","author":"Vichinsky","year":"2001","journal-title":"Transfusion"},{"key":"R34-4-20210206","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1537-2995.1987.27187121485.x","article-title":"Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy","volume":"27","author":"Ambruso","year":"1987","journal-title":"Transfusion"},{"key":"R35-4-20210206","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1537-2995.1994.34794330008.x","article-title":"Antigen-matched donor blood in the transfusion management of patients with sickle cell disease","volume":"34","author":"Tahhan","year":"1994","journal-title":"Transfusion"},{"key":"R36-4-20210206","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2141.2001.02819.x","article-title":"Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom","volume":"113","author":"Olujohungbe","year":"2001","journal-title":"Br J Haematol"},{"key":"R37-4-20210206","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5858\/2005-129-190-PMODRB","article-title":"Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories","volume":"129","author":"Osby","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"R38-4-20210206","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tmrv.2005.11.002","article-title":"Bystander immune cytolysis","volume":"20","author":"Petz","year":"2006","journal-title":"Transfus Med Rev"},{"key":"R39-4-20210206","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1537-2995.1997.37497265338.x","article-title":"The sickle cell hemolytic transfusion reaction syndrome","volume":"37","author":"Petz","year":"1997","journal-title":"Transfusion"},{"key":"R40-4-20210206","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1537-2995.2006.00679.x","article-title":"Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia","volume":"46","author":"Ballas","year":"2006","journal-title":"Transfusion"},{"key":"R41-4-20210206","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1182\/blood-2008-07-077370","article-title":"The hazards of blood transfusion in historical perspective","volume":"112","author":"Alter","year":"2008","journal-title":"Blood"},{"key":"R42-4-20210206","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1053\/beha.2000.0104","article-title":"The risks of transfusion-transmitted infection: direct estimation and mathematical modelling","volume":"13","author":"Kleinman","year":"2000","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"key":"R43-4-20210206","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1128\/CMR.18.1.195-204.2005","article-title":"Bacterial contamination of blood components","volume":"18","author":"Brecher","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R44-4-20210206","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2008.03.003","article-title":"Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia","volume":"43","author":"Fung","year":"2008","journal-title":"Bone"},{"key":"R45-4-20210206","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/blood.V96.1.76","article-title":"Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy","volume":"96","author":"Harmatz","year":"2000","journal-title":"Blood"},{"key":"R46-4-20210206","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance","volume":"115","author":"Tanner","year":"2007","journal-title":"Circulation"},{"key":"R47-4-20210206","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1532-429X-10-12","article-title":"Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction","volume":"10","author":"Tanner","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"R48-4-20210206","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tmrv.2007.12.002","article-title":"Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services","volume":"22","author":"Hillyer","year":"2008","journal-title":"Transfus Med Rev"},{"key":"R49-4-20210206","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1537-2995.2007.01468.x","article-title":"Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis","volume":"47","author":"Zimring","year":"2007","journal-title":"Transfusion"},{"key":"R50-4-20210206","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1537-2995.2002.00029.x","article-title":"DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients","volume":"42","author":"Castilho","year":"2002","journal-title":"Transfusion"},{"key":"R51-4-20210206","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.moh.0000245695.77758.3d","article-title":"Molecular testing for transfusion medicine","volume":"13","author":"Westhoff","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"R52-4-20210206","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pcl.2008.02.003","article-title":"Hydroxyurea for children with sickle cell disease.","volume":"55","author":"Heeney","year":"2008","journal-title":"Pediatr Clin North Am"},{"key":"R53-4-20210206","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood.V97.11.3628","article-title":"Five years of experience with hydroxyurea in children and young adults with sickle cell disease","volume":"97","author":"Ferster","year":"2001","journal-title":"Blood"},{"key":"R54-4-20210206","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood-2006-11-057893","article-title":"Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia","volume":"110","author":"Zimmerman","year":"2007","journal-title":"Blood"},{"key":"R55-4-20210206","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/pbc.20903","article-title":"Therapy preference and decision-making among patients with severe sickle cell anemia and their families","volume":"48","author":"Hankins","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R57-4-20210206","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/08880010701360650","article-title":"Hemopure transfusion in a child with severe anemia","volume":"24","author":"Stefan","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"R58-4-20210206","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jamcollsurg.2004.07.025","article-title":"Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage","volume":"199","author":"Fitzpatrick","year":"2004","journal-title":"J Am Coll Surg"},{"key":"R59-4-20210206","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/08880010701481100","article-title":"Hemoglobin-based oxygen carriers: a long road from bench to bedside","volume":"24","author":"Quirolo","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"R60-4-20210206","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2141.2007.06822.x","article-title":"Clinical differences between children and adults with pulmonary hypertension and sickle cell disease","volume":"140","author":"Hagar","year":"2008","journal-title":"Br J Haematol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e328321882e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:56:14Z","timestamp":1786038974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-200902000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e328321882e","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}